Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
An EF hand mutation in Stim1 causes premature platelet activation and bleeding in mice
Johannes Grosse, Attila Braun, David Varga-Szabo, Niklas Beyersdorf, Boris Schneider, Lutz Zeitlmann, Petra Hanke, Patricia Schropp, Silke Mühlstedt, Carolin Zorn, Michael Huber, Carolin Schmittwolf, Wolfgang Jagla, Philipp Yu, Thomas Kerkau, Harald Schulze, Michael Nehls, Bernhard Nieswandt
Johannes Grosse, Attila Braun, David Varga-Szabo, Niklas Beyersdorf, Boris Schneider, Lutz Zeitlmann, Petra Hanke, Patricia Schropp, Silke Mühlstedt, Carolin Zorn, Michael Huber, Carolin Schmittwolf, Wolfgang Jagla, Philipp Yu, Thomas Kerkau, Harald Schulze, Michael Nehls, Bernhard Nieswandt
View: Text | PDF
Research Article Hematology

An EF hand mutation in Stim1 causes premature platelet activation and bleeding in mice

  • Text
  • PDF
Abstract

Changes in cytoplasmic Ca2+ levels regulate a variety of fundamental cellular functions in virtually all cells. In nonexcitable cells, a major pathway of Ca2+ entry involves receptor-mediated depletion of intracellular Ca2+ stores followed by the activation of store-operated calcium channels in the plasma membrane. We have established a mouse line expressing an activating EF hand motif mutant of stromal interaction molecule 1 (Stim1), an ER receptor recently identified as the Ca2+ sensor responsible for activation of Ca2+ release–activated (CRAC) channels in T cells, whose function in mammalian physiology is not well understood. Mice expressing mutant Stim1 had macrothrombocytopenia and an associated bleeding disorder. Basal intracellular Ca2+ levels were increased in platelets, which resulted in a preactivation state, a selective unresponsiveness to immunoreceptor tyrosine activation motif–coupled agonists, and increased platelet consumption. In contrast, basal Ca2+ levels, but not receptor-mediated responses, were affected in mutant T cells. These findings identify Stim1 as a central regulator of platelet function and suggest a cell type–specific activation or composition of the CRAC complex.

Authors

Johannes Grosse, Attila Braun, David Varga-Szabo, Niklas Beyersdorf, Boris Schneider, Lutz Zeitlmann, Petra Hanke, Patricia Schropp, Silke Mühlstedt, Carolin Zorn, Michael Huber, Carolin Schmittwolf, Wolfgang Jagla, Philipp Yu, Thomas Kerkau, Harald Schulze, Michael Nehls, Bernhard Nieswandt

×

Figure 6

A selective ITAM signaling defect in Stim1Sax/+ platelets.

Options: View larger image (or click on image) Download as PowerPoint
A selective ITAM signaling defect in Stim1Sax/+ platelets.
             ...
(A and B) Oregon Green BAPTA-1/FuraRed–loaded platelets were stimulated with 5 μM TG for 10 minutes followed by addition of extracellular Ca2+, and [Ca2+]i was monitored by flow cytometry. Representative measurements (A) and maximal [Ca2+]i ± SD (n = 6 per group) before and after addition of 2 mM Ca2+ (B) are shown. (C and D) Oregon Green BAPTA-1/FuraRed–loaded platelets were stimulated with the indicated agonists in the presence of 2 mM Ca2+, and [Ca2+]i was monitored by flow cytometry. Representative measurements (C) and maximal [Ca2+]i ± SD (n = 6 per group) (D) are shown. (E) WT and Stim1Sax/+ platelets were stimulated with the indicated agonists, incubated with fluorophore-labeled antibodies to detect integrin αIIbβ3 activation (JON/A-PE) and degranulation (anti–P-selectin FITC), and analyzed directly. Platelets were gated by forward-scatter/side-scatter characteristics and FL4 positivity (anti-GPIb-Cy5). The results shown are representative of 12 experiments.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts